High-priority alert based on source significance and keyword relevance.
Context
What happened: Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Alphatec Holdings, Inc. (NASDAQ:ATEC) securities.
Key numbers: Q3 2026 adjusted EPS $0.09 and revenue $221.2 million, both below analyst expectations.
Why it matters: The firm cites the guidance cut, which the company attributed to lower biologics attachment rates, softer procedure volumes, EOS timing, and a temporary international supply constraint, and the subsequent share price drop.
What changed
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Alphatec Holdings, Inc. (NASDAQ:ATEC) securities.
Why it matters
The firm cites the guidance cut, which the company attributed to lower biologics attachment rates, softer procedure volumes, EOS timing, and a temporary international supply constraint, and the subsequent share price drop.